https://adisinsight.springer.com/trials/700391176?error=cookies_not_supported&code=6225c9b4-e931-4580-bb23-a6ae56db4da4
A Phase 1b/2 Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SG2918...
The primary objective of this study was to evaluate the safety and tolerability of SG2918 in patients with relapsed/refractory multiple myeloma.